(7429.31052017.113000246) NOVIFRA (Q2460624)

From EU Knowledge Graph
Revision as of 09:09, 4 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr, and other parts: Adding French translations)
Jump to navigation Jump to search
Project Q2460624 in Italy
Language Label Description Also known as
English
(7429.31052017.113000246) NOVIFRA
Project Q2460624 in Italy

    Statements

    0 references
    33,775.0 Euro
    0 references
    67,550.0 Euro
    0 references
    50.0 percent
    0 references
    25 September 2017
    0 references
    25 March 2019
    0 references
    2 October 2019
    0 references
    NEXT TECHNOLOGY TECNOTESSILE SOCIETA' NAZIONALE DI RICERCA R.L.
    0 references
    0 references
    0 references

    43°46'11.53"N, 11°15'20.09"E
    0 references
    IL PROGETTO ?NOVIFRA? NASCE DALL?IDEA DI AIUTARE E CURARE LA COSIDDETTA ?UTENZA FRAGILE?, OVVERO PERSONE AFFETTE DA DEFICIT COGNITIVI O EMOZIONALI DI VARIO LIVELLO (DA ALZHEIMER NEI CASI PI? GRAVI E FREQUENTI), ATTRAVERSO DELLE TERAPIE CHE NON HANNO NEL FARMACO IL MEZZO PER GARANTIRE UNA VITA SERENA AI PAZIENTI, METTENDOLI MAGARI IN CONDIZIONE DI MANTENERE UN BUON GRADO DI AUTONOMIA SENZA DOVER SOPPORTARE EFFETTI COLLATERALI LEGATI ALL?ASSUNZIONE DI FARMACI. SOPRATTUTTO, L?IDEA CHE MUOVE LA REALIZZAZIONE DEI NUOVI SISTEMI ? PROPRIO L?INCREMENTO DELL?EFFICACIA DELLE TERAPIE NON FARMACOLOGICHE E QUINDI IL MIGLIORAMENTO DEL BENESSERE PERSONALE E DELLE CONDIZIONI DI VITA DEGLI UTENTI FRAGILI, SONO STATI PRESI A RIFERIMENTO SISTEMI SIMILARI SVILUPPATI IN AMBITI COMPLETAMENTE DIVERSI, OVVERO NEL MONDO INDUSTRIALE, DOVE SI MASSIMIZZA L?EFFICACIA DEI FLUSSI DI MATERIALI ATTRAVERSO LA LORO TRACCIABILIT? E L?ELABORAZIONE DELLA MOLE DI DATI RACCOLTI SUI FLUSSI STESSI.COME AFFERMA LO STUDIO REVISI (Italian)
    0 references
    THE PROJECT? NOVIFRA? DO YOU START FROM THE IDEA OF HELPING AND TREATING WHAT IS KNOWN AS A FRAGILE USER OR WITH COGNITIVE OR EMOTIONAL DEFICITS AT VARIOUS LEVELS (FROM ALZHEIMER’S IN IP CASES? WITH TREATMENTS THAT DO NOT HAVE THE MEANS OF ENSURING A LIFE SERENA TO PATIENTS, AND PERHAPS IN A POSITION TO MAINTAIN A GOOD DEGREE OF AUTONOMY WITHOUT HAVING TO BEAR SIDE EFFECTS LINKED TO THE RECRUITMENT OF MEDICINES, THROUGH TREATMENTS THAT DO NOT HAVE THE MEDICINE IN THE MEDICINE TO ENSURE A LIFE SERENA TO PATIENTS. ABOVE ALL, WHAT IS THE IDEA OF IMPLEMENTING THE NEW SYSTEMS? IS IT PRECISELY THE INCREASE IN THE EFFECTIVENESS OF NON-PHARMACEUTICAL THERAPIES AND THEREFORE THE IMPROVEMENT OF THE PERSONAL WELL-BEING AND LIVING CONDITIONS OF FRAGILE USERS, ARE SIMILAR SYSTEMS DEVELOPED IN COMPLETELY DIFFERENT AREAS, I.E. IN THE INDUSTRIAL WORLD, WHERE THE EFFECTIVENESS OF MATERIAL FLOWS THROUGH THEIR ACCIABILIT IS MAXIMISED? E L? DEVELOPMENT OF THE AMOUNT OF DATA COLLECTED ON THE STESSI.AS THE REVISI STUDY SAYS (English)
    0 references
    LE PROJET?NOVIFRA? EST-IL NÉ DE L’IDÉE D’AIDER ET DE TRAITER LES SOI-DISANT UTILISATEURS «FRAILISÉS»?E.I. PERSONNES SOUFFRANT DE DÉFICIENCES COGNITIVES OU ÉMOTIONNELLES DE DIFFÉRENTS NIVEAUX (DE LA MALADIE D’ALZHEIMER DANS LES CAS DE PI? SÉRIEUX ET FRÉQUENTS), À TRAVERS DES THÉRAPIES QUI N’ONT PAS DANS LE MÉDICAMENT LES MOYENS DE GARANTIR UNE VIE SERENA AUX PATIENTS, PEUT-ÊTRE EN LES METTANT EN MESURE DE MAINTENIR UN BON DEGRÉ D’AUTONOMIE SANS AVOIR À SUPPORTER DES EFFETS SECONDAIRES LIÉS À LA PRISE DE MÉDICAMENTS. SURTOUT, L’IDÉE QUI DÉPLACE LA MISE EN ŒUVRE DES NOUVEAUX SYSTÈMES? PRÉCISÉMENT L’AUGMENTATION DE L’EFFICACITÉ DES THÉRAPIES NON PHARMACOLOGIQUES ET, PARTANT, L’AMÉLIORATION DU BIEN-ÊTRE PERSONNEL ET DES CONDITIONS DE VIE DES UTILISATEURS FRAGILES, ONT ÉTÉ PRISES EN RÉFÉRENCE À DES SYSTÈMES SIMILAIRES DÉVELOPPÉS DANS DES DOMAINES COMPLÈTEMENT DIFFÉRENTS, I.E. DANS LE MONDE INDUSTRIEL, OÙ L’EFFICACITÉ DES FLUX DE MATÉRIAUX GRÂCE À LEUR TRAÇABILITÉ EST MAXIMISÉE? ET LE TRAITEMENT DE LA QUANTITÉ DE DONNÉES COLLECTÉES SUR STESSI FLOWS.AS L’ÉTUDE REVISI ETATS (French)
    4 January 2022
    0 references

    Identifiers